CA2199273A1 - Epimers of (22rs)-n-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-oxo-4-aza-5.alpha.-androst-1-ene-17.beta.-carboxamide - Google Patents
Epimers of (22rs)-n-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-oxo-4-aza-5.alpha.-androst-1-ene-17.beta.-carboxamideInfo
- Publication number
- CA2199273A1 CA2199273A1 CA002199273A CA2199273A CA2199273A1 CA 2199273 A1 CA2199273 A1 CA 2199273A1 CA 002199273 A CA002199273 A CA 002199273A CA 2199273 A CA2199273 A CA 2199273A CA 2199273 A1 CA2199273 A1 CA 2199273A1
- Authority
- CA
- Canada
- Prior art keywords
- epimers
- formula
- phenylprop
- trifluoro
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI95A001587 | 1995-07-21 | ||
| IT95MI001587A IT1275594B1 (it) | 1995-07-21 | 1995-07-21 | Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5alfa-androst-1-ene-17beta-carbossammide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2199273A1 true CA2199273A1 (en) | 1997-02-06 |
Family
ID=11372032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002199273A Abandoned CA2199273A1 (en) | 1995-07-21 | 1996-06-28 | Epimers of (22rs)-n-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-oxo-4-aza-5.alpha.-androst-1-ene-17.beta.-carboxamide |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0782582A1 (es) |
| JP (1) | JPH10506411A (es) |
| KR (1) | KR970706298A (es) |
| CN (1) | CN1159195A (es) |
| AR (1) | AR003967A1 (es) |
| AU (1) | AU6418396A (es) |
| BR (1) | BR9606527A (es) |
| CA (1) | CA2199273A1 (es) |
| EA (1) | EA199700045A1 (es) |
| HU (1) | HUP9702465A3 (es) |
| IL (1) | IL120343A0 (es) |
| IT (1) | IT1275594B1 (es) |
| MX (1) | MX9701948A (es) |
| NO (1) | NO971196D0 (es) |
| PL (1) | PL319351A1 (es) |
| WO (1) | WO1997004002A1 (es) |
| ZA (1) | ZA965678B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6137399A (en) * | 1998-09-09 | 2000-03-27 | Merck & Co., Inc. | Method of determining and reducing the risk of bph-related urologic events |
| ES2237408T3 (es) * | 1999-01-25 | 2005-08-01 | Smithkline Beecham Corporation | Antiandrogenos y procedimientos para tratar una enfermedad. |
| CN100355772C (zh) * | 2005-12-28 | 2007-12-19 | 天津大学 | 具有5α－还原酶抑制活性的甾体化合物及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9216284D0 (en) * | 1992-07-31 | 1992-09-16 | Erba Carlo Spa | Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives |
-
1995
- 1995-07-21 IT IT95MI001587A patent/IT1275594B1/it active IP Right Grant
-
1996
- 1996-06-28 BR BR9606527A patent/BR9606527A/pt not_active Application Discontinuation
- 1996-06-28 CN CN96190785A patent/CN1159195A/zh active Pending
- 1996-06-28 WO PCT/EP1996/002830 patent/WO1997004002A1/en not_active Application Discontinuation
- 1996-06-28 PL PL96319351A patent/PL319351A1/xx unknown
- 1996-06-28 AU AU64183/96A patent/AU6418396A/en not_active Abandoned
- 1996-06-28 HU HU9702465A patent/HUP9702465A3/hu unknown
- 1996-06-28 KR KR1019970701797A patent/KR970706298A/ko not_active Application Discontinuation
- 1996-06-28 CA CA002199273A patent/CA2199273A1/en not_active Abandoned
- 1996-06-28 EP EP96923968A patent/EP0782582A1/en not_active Withdrawn
- 1996-06-28 MX MX9701948A patent/MX9701948A/es unknown
- 1996-06-28 JP JP9506217A patent/JPH10506411A/ja active Pending
- 1996-06-28 IL IL12034396A patent/IL120343A0/xx unknown
- 1996-07-04 ZA ZA965678A patent/ZA965678B/xx unknown
- 1996-07-19 AR ARP960103652A patent/AR003967A1/es unknown
-
1997
- 1997-03-14 NO NO971196A patent/NO971196D0/no unknown
- 1997-04-18 EA EA199700045A patent/EA199700045A1/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI951587A0 (it) | 1995-07-21 |
| HUP9702465A2 (hu) | 1998-05-28 |
| IL120343A0 (en) | 1997-06-10 |
| AU6418396A (en) | 1997-02-18 |
| AR003967A1 (es) | 1998-09-30 |
| BR9606527A (pt) | 1997-12-23 |
| EA199700045A1 (ru) | 1997-12-30 |
| NO971196L (no) | 1997-03-14 |
| CN1159195A (zh) | 1997-09-10 |
| MX9701948A (es) | 1997-06-28 |
| EP0782582A1 (en) | 1997-07-09 |
| IT1275594B1 (it) | 1997-08-06 |
| PL319351A1 (en) | 1997-08-04 |
| ITMI951587A1 (it) | 1997-01-21 |
| WO1997004002A1 (en) | 1997-02-06 |
| KR970706298A (ko) | 1997-11-03 |
| ZA965678B (en) | 1997-01-24 |
| JPH10506411A (ja) | 1998-06-23 |
| NO971196D0 (no) | 1997-03-14 |
| HUP9702465A3 (en) | 1998-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0591057B1 (fr) | Arylalkyl(thio)amides ayant une affinité sélective pour les récepteurs de la mélatonine et leur procédé de préparation | |
| CA2406847C (en) | Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols | |
| EP0799239B1 (en) | Diastereomerically pure 3-oxo and 3-thioxo-4-aza-androstan derivatives and the use thereof as antiandrogens | |
| US5237061A (en) | Methods of synthesizing benign prostatic hypertropic agents and their intermediates | |
| SK128494A3 (en) | Method of production of indanylamine compounds | |
| JPH06511497A (ja) | フッ素化１７β−置換，４−アザ−５α−アンドロスタン−３−オン誘導体 | |
| NZ244640A (en) | 17beta-substituted aza-androstane derivatives; pharmaceutical compositions and preparatory processes | |
| US4797411A (en) | Cycloalkyl-substituted 4-pyridyl derivatives and use as aromatase inhibitors | |
| CA2199273A1 (en) | Epimers of (22rs)-n-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-oxo-4-aza-5.alpha.-androst-1-ene-17.beta.-carboxamide | |
| HU198441B (en) | Process for production of derivatives of 4-amin-phenil substituated by cycloalkil group and their medically acceptable salts and medical compositions containing such compounds | |
| FR2601011A1 (fr) | Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant | |
| CA2253912C (en) | Taxane derivatives, the preparation thereof and formulations containing them | |
| EP0115979A1 (fr) | Nouveaux dérivés du 1H,3H-pyrrolo (1,2-c) thiazole leur préparation et les médicaments qui les contiennent | |
| CZ146097A3 (en) | Fluorinated derivative of 4-azasteroid being substituted on a phenyl group, process of its preparation and pharmaceutical composition containing thereof | |
| Srivastava et al. | N-benzoyl-(2R, 3S)-3-phenylisoserine methyl ester; a facile and convenient synthesis and resolution by entrainment | |
| MXPA97001948A (es) | Epimeros de (22rs-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-oxo-4-aza-5alfa-androst-1-en-17beta-carboxamida | |
| Heinrich et al. | Effective syntheses of quinoline-7, 8-diol, 5-amino-l-DOPA, and 3-(7, 8-dihydroxyquinolin-5-yl)-l-alanine | |
| EP0276122B1 (en) | Cycloalkyl-substituted 4-aminophenyl halo derivatives and process for their preparation | |
| US5583228A (en) | 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof | |
| AU696320B2 (en) | 4-aza-19-norandrostane derivatives | |
| IE60754B1 (en) | Steroidic aromatase inhibitors | |
| JP2003509504A (ja) | リトナビルの合成方法 | |
| BE1000112A5 (fr) | Procede de preparation d'encainide. | |
| CN102838653B (zh) | 一种3-羰基-4-氮杂-5α-雄甾化合物的制备方法 | |
| CN116217478A (zh) | 一种6-氨基-3-二氟甲基喹啉的合成方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |